I thought I would start this thread to discuss drug delivery as a potential indication, as I think it has the potential to be really quite transformative for the company, and provide a revenue opportunity in the future far greater than MIGS alone. There's actually a decent amount of information already available, a few studies conducted a while back etc.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
-0.005(3.45%) |
Mkt cap ! $39.85M | |||
| Open | High | Low | Value | Volume |
| 14.5¢ | 15.0¢ | 14.0¢ | $34.30K | 241.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 169738 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| EYE (ASX) Chart |